Related references
Note: Only part of the references are listed.Wnt5a suppresses osteoblastic differentiation of human periodontal ligament stem cell-like cells via Ror2/JNK signaling
Daigaku Hasegawa et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
WNT5A induces castration-resistant prostate cancer via CCL2 and tumour-infiltrating macrophages
Geun Taek Lee et al.
BRITISH JOURNAL OF CANCER (2018)
Current perspectives on bone metastases in castrate-resistant prostate cancer
Christopher Logothetis et al.
CANCER AND METASTASIS REVIEWS (2018)
Decreased TGFBR3/betaglycan expression enhances the metastatic abilities of renal cell carcinoma cells through TGF-β-dependent and-independent mechanisms
Jun Nishida et al.
ONCOGENE (2018)
Role of WNT5A receptors FZD5 and RYK in prostate cancer cells
Stefanie Thiele et al.
Oncotarget (2018)
Signaling Cross Talk between TGF-beta/Smad and Other Signaling Pathways
Kunxin Luo
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2017)
Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review)
Masaru Katoh
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
Treatment with the WNT5A-mimicking peptide Foxy-5 effectively reduces the metastatic spread of WNT5A-low prostate cancer cells in an orthotopic mouse model
Giacomo Canesin et al.
PLOS ONE (2017)
Altering the Proteoglycan State of Transforming Growth Factor Type III Receptor (TRIII)/Betaglycan Modulates Canonical Wnt/-Catenin Signaling
Laura M. Jenkins et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
WNT5A and Its Receptors in the Bone-Cancer Dialogue
Stefanie Thiele et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2016)
Thrombospondin-1 promotes mesenchymal stromal cell functions via TGFβ and in cooperation with PDGF
Dorina Belotti et al.
MATRIX BIOLOGY (2016)
Predictive computational modeling to define effective treatment strategies for bone metastatic prostate cancer
Leah M. Cook et al.
SCIENTIFIC REPORTS (2016)
The TGF-β Signaling Regulator PMEPA1 Suppresses Prostate Cancer Metastases to Bone
Pierrick G. J. Fournier et al.
CANCER CELL (2015)
WNT5A Has Anti-Prostate Cancer Effects In Vitro and Reduces Tumor Growth in the Skeleton In Vivo
Stefanie Thiele et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2015)
Bone metastasis and the metastatic niche
Guangwen Ren et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2015)
RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance
David T. Miyamoto et al.
SCIENCE (2015)
Current and Emerging Therapies for Bone Metastatic Castration-Resistant Prostate Cancer
Jeremy S. Frieling et al.
CANCER CONTROL (2015)
Type III Transforming Growth Factor Beta Receptor Regulates Vascular and Osteoblast Development During Palatogenesis
Cynthia R. Hill et al.
DEVELOPMENTAL DYNAMICS (2015)
Integrating new discoveries into the vicious cycle paradigm of prostate to bone metastases
Leah M. Cook et al.
CANCER AND METASTASIS REVIEWS (2014)
An Integrated Computational Model of the Bone Microenvironment in Bone-Metastatic Prostate Cancer
Arturo Araujo et al.
CANCER RESEARCH (2014)
Cabozantinib Inhibits Prostate Cancer Growth and Prevents Tumor-Induced Bone Lesions
Jinlu Dai et al.
CLINICAL CANCER RESEARCH (2014)
Bone marrow mesenchymal stem cells and TGF-β signaling in bone remodeling
Janet L. Crane et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
TGF-β family signaling in stem cells
Masayo Sakaki-Yumoto et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2013)
TGF-β Mediates Homing of Bone Marrow-Derived Human Mesenchymal Stem Cells to Glioma Stem Cells
Naoki Shinojima et al.
CANCER RESEARCH (2013)
Noncanonical WNT-5A signaling regulates TGF-β-induced extracellular matrix production by airway smooth muscle cells
Kuldeep Kumawat et al.
FASEB JOURNAL (2013)
TGF-β2 dictates disseminated tumour cell fate in target organs through TGF-β-RIII and p38α/β signalling
Paloma Bragado et al.
NATURE CELL BIOLOGY (2013)
WNT5A Encodes Two Isoforms with Distinct Functions in Cancers
Matthieu Bauer et al.
PLOS ONE (2013)
Abi3bp Is a Multifunctional Autocrine/Paracrine Factor that Regulates Mesenchymal Stem Cell Biology
Conrad P. Hodgkinson et al.
STEM CELLS (2013)
Role of non-canonical Wnt signaling in osteoblast maturation on microstructured titanium surfaces
Rene Olivares-Navarrete et al.
ACTA BIOMATERIALIA (2011)
TGF-β and its coreceptors in cancerogenesis: an overview
Natasa Todorovic-Rakovic et al.
BIOMARKERS IN MEDICINE (2011)
TGF-beta in cancer and bone: Implications for treatment of bone metastases
Patricia Juarez et al.
BONE (2011)
TGF-beta-RI Kinase Inhibitor SD-208 Reduces the Development and Progression of Melanoma Bone Metastases
Khalid S. Mohammad et al.
CANCER RESEARCH (2011)
Wnt5a as an Effector of TGFβ in Mammary Development and Cancer
Rosa Serra et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2011)
Betaglycan: A multifunctional accessory
Maree Bilandzic et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2011)
Anti-Transforming Growth Factor β Antibody Treatment Rescues Bone Loss and Prevents Breast Cancer Metastasis to Bone
Swati Biswas et al.
PLOS ONE (2011)
Targeting the transforming growth factor-β signalling pathway in metastatic cancer
Manav Korpal et al.
EUROPEAN JOURNAL OF CANCER (2010)
Inhibition of TGF-β Signaling by 1D11 Antibody Treatment Increases Bone Mass and Quality In Vivo
James R. Edwards et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Roles of TGF-beta family signaling in stem cell renewal and differentiation
Tetsuro Watabe et al.
CELL RESEARCH (2009)
Imaging transforming growth factor-β signaling dynamics and therapeutic response in breast cancer bone metastasis
Manav Korpal et al.
NATURE MEDICINE (2009)
TGF-β1-induced migration of bone mesenchymal stem cells couples bone resorption with formation
Yi Tang et al.
NATURE MEDICINE (2009)
The type III TGF-β receptor regulates epithelial and cancer cell migration through β-arrestin2-mediated activation of Cdc42
Karthikeyan Mythreye et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Wnt5a is required for proper mammary gland development and TGF-β-mediated inhibition of ductal growth
Kevin Roarty et al.
DEVELOPMENT (2007)
The type III transforming growth factor-β receptor as a novel tumor suppressor gene in prostate cancer
Ryan S. Turley et al.
CANCER RESEARCH (2007)
The type III TGF-beta receptor suppresses breast cancer progression
Mei Dong et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
TGFβ:: the molecular Jekyll and Hyde of cancer
Brian Bierie et al.
NATURE REVIEWS CANCER (2006)
Regulation of bone mass by Wnt signaling
V Krishnan et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
TGF-β regulates the mechanical properties and composition of bone matrix
G Balooch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Transforming growth factor-β1 to the bone
K Janssens et al.
ENDOCRINE REVIEWS (2005)
Transforming growth factor-beta in osteolytic breast cancer bone metastases
TA Guise et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2003)
PANTHER: A library of protein families and subfamilies indexed by function
PD Thomas et al.
GENOME RESEARCH (2003)
Heart and liver defects and reduced transforming growth factor β2 sensitivity in transforming growth factor β type III receptor-deficient embryos
KL Stenvers et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
A multigenic program mediating breast cancer metastasis to bone
YB Kang et al.
CANCER CELL (2003)
Betaglycan expression is transcriptionally up-regulated during skeletal muscle differentiation -: Cloning of murine betaglycan gene promoter and its modulation by myoD, retinoic acid, and transforming growth factor-β
F López-Casillas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Betaglycan inhibits TGF-β signaling by preventing type I-type II receptor complex formation -: Glycosaminoglycan modifications alter betaglycan function
O Eickelberg et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Comparison of human adult and fetal expression and identification of 535 housekeeping/maintenance genes
JA Warrington et al.
PHYSIOLOGICAL GENOMICS (2000)